AI in Retina: Accuracy First - Summary - MDSpire

AI in Retina: Accuracy First

Ophthalmic patients want accuracy in their clinical decisions, regardless of who makes that decision

  • February 3, 2026

  • 2 min

Share

Objective:

To assess patient comfort and acceptance of AI in making retreatment decisions for macular disease based on retinal imaging.

Key Findings:
  • Error rate (34.4%) and presence of a second reader/checker (33.6%) were the most important factors for patient confidence in AI.
  • Participants showed no significant preference for human versus AI as the first reader.
  • Many participants suggested that a human making final decisions with AI support could be ideal.
Interpretation:

Patients prioritize reliability and verification in AI-led treatment decisions over the identity of the decision-maker, indicating a potential pathway for successful AI integration in clinical practice.

Limitations:
  • The study had a limited sample size with only 181 complete responses.
  • Responses may not fully represent the broader patient population due to recruitment method.
Conclusion:

To facilitate AI adoption in macular clinics, focus should be on ensuring high performance, accuracy, and transparency rather than on promoting AI technology itself.

Original Source(s)

AI in Retina: Accuracy First

  • February 3, 2026

Related Content

Video: No Evidence That AREDS Vitamins Slow GA Progression

A post hoc analysis of OAKS and DERBY data failed to support the foveal protection suggested by an earlier AREDS study.

New Product Applications: Introducing the Cirrus 6000

Discover how Zeiss's Cirrus 6000 OCT device revolutionizes eye care with faster analysis and enhanced capabilities for disease diagnosis and treatment.

Faster, Reliable, Patient-centered: What’s Next for SPECTRALIS<sup>®</sup>

Upcoming SPECTRALIS Software Version brings new speed, workflow flexibility, and diagnostic depth to multimodal retinal imaging

  • December 9, 2025

  • 5 min